Recombinant subunit vaccines |
| |
Authors: | W. Neal Burnette |
| |
Affiliation: | Amgen Inc., Thousand Oaks, California. |
| |
Abstract: | Research that may lead to the development of recombinant DNA-based vaccines has been conducted on a broad front. This has resulted in an increased understanding of immunological responsiveness to vaccines, the rational engineering of immunogens, and new means of delivering vaccines. |
| |
Keywords: | |
本文献已被 ScienceDirect 等数据库收录! |
|